J Neurosci Res, 2011 · DOI: 10.1002/jnr.22557 · Published: March 1, 2011
The study investigates how increasing the expression of a molecule called major histocompatibility complex class I (MHCI) in neurons affects recovery after spinal cord injury (SCI) in mice. Transgenic mice were created to have higher levels of MHCI in their neurons, and then subjected to SCI. The researchers then compared their recovery to that of normal mice. The key finding was that the transgenic mice with enhanced MHCI expression in neurons showed significantly better recovery of their locomotor abilities after SCI compared to wild-type mice.
Up-regulation of MHCI in spinal cord neurons could be a therapeutic target for promoting recovery after SCI.
Pharmacological or gene therapy approaches could be developed to enhance MHCI expression in neurons after SCI.
Further research is needed to characterize the specific immune responses to neuronal antigens in NSE-Db mice versus wild-type mice to better understand the mechanisms involved.